![]() |
市场调查报告书
商品编码
2000523
全球冷却凝胶片市场预测至2034年-按产品类型、目标使用者、材料类型、通路、应用、最终使用者和地区分類的分析Cooling Gel Sheet Market Forecasts to 2034 - Global Analysis By Product Type (Disposable, and Reusable), Target User (Infant, Children, and Adult), Material Type, Distribution Channel, Application, End User, and By Geography |
||||||
根据 Stratistics MRC 的数据,预计到 2026 年,全球冷却凝胶片市场规模将达到 11.5 亿美元,在预测期内复合年增长率为 7.4%,到 2034 年将达到 20.4 亿美元。
冷却凝胶贴片是一种医疗和个人保健产品,旨在为退烧、缓解头痛和轻微损伤提供局部冷却疗法。这些贴片紧密贴合肌肤,提供持续的冷却效果,且无需像传统冰袋那样造成不便。随着消费者对非药物退烧疗法的认识不断提高,市场正在不断扩大,尤其是在居家医疗领域。
发烧及相关疾病增多
季节性发烧、病毒感染疾病和发烧相关疾病病例的不断增加,推动了人们对便利降温解决方案的需求。消费者,尤其是家有儿童和老人的家庭,越来越倾向于选择便利的非药物疗法来缓解居家症状。冰凉凝胶贴片因其能迅速缓解症状且无口服药物的副作用,已成为值得信赖的首选。不断上涨的医疗成本也促使人们更加重视自我护理,进一步推动了这个趋势。
冷却效果持续时间短
一次性冰敷纸的降温效果相对较短,通常只能持续4到8小时,这对于需要长期缓解症状的使用者来说是一个限制。频繁更换会增加整体成本并产生包装废弃物,这可能会降低使用者经常使用的频率。有些消费者认为一次性冰敷纸不如可重复使用的冰袋经济。这种限制导致人们更倾向于选择其他降温方法来应对持续发烧症状。
拓展至运动医学及术后復健领域。
运动伤害管理和术后护理领域尚未开发的应用为冷却凝胶片生产商带来了巨大的成长机会。运动员越来越多地采用局部冷却疗法来减轻发炎、加速康復。医院和诊所也在寻求比笨重冰袋更方便患者使用的替代方案来控制术后肿胀。这些新的应用场景正在拓展消费者群体,使其不再局限于传统的退烧用途。
与替代冷冻疗法的竞争
冷却凝胶片市场面临来自可重复使用凝胶包、电子冷却设备和传统冷敷的激烈竞争。这些替代品通常具有更长的冷却时间和更低的生命週期成本。消费者更有可能选择多功能产品而非专用凝胶片。此外,穿戴式冷却技术的兴起也构成颠覆性威胁,如果创新跟不上步伐,可能会侵蚀市场份额。
疫情期间,人们更加意识到退烧是新冠肺炎的主要症状之一,这加速了降温凝胶片在家中的使用。囤积行为导致了暂时的供不应求。居家隔离增加了人们对自我护理产品的依赖,而医院则优先采用非药物退烧方法以降低医护人员的感染风险。这段时期导致降温产品的基本需求持续成长。
在预测期内,一次性用品市场预计将成为最大的细分市场。
一次性冰敷贴因其便捷、卫生和即用型的特征而占据市场主导地位。使用者青睐其一次性使用的特性,无需清洗和储存,尤其在婴幼儿发烧照护中,由于污染风险较高,其便利性更为显着。这些冰敷贴在药局和线上零售商处均有销售,方便用户购买。消费者对其的信赖和实惠的价格使其在市场上保持主导地位。
在预测期内,预计成人细分市场将呈现最高的复合年增长率。
预计成年用户群将呈现最高的成长率,这主要得益于其用途的拓展,从退烧扩展到缓解头痛、运动后恢復以及减轻更年期潮热。上班族越来越多地使用降温贴来缓解压力引起的紧张性头痛和通勤途中的热应激。针对积极生活方式和运动后復原的行销宣传活动正在扩大年轻成年人的接受度,从而创造持续的需求。
在预测期内,亚太地区预计将占据最大的市场份额,这主要得益于该地区人口密度高、发烧季节频繁以及人们对退烧产品较高的文化接受度。日本、中国和印度等国家凭藉其广泛的零售网络和较高的消费者意识,已建立了成熟的市场。该地区人口老化和不断壮大的中产阶级也进一步推动了对便利居家医疗解决方案的需求。
在预测期内,北美预计将呈现最高的复合年增长率,这主要得益于消费者对非药物症状管理的认知不断提高以及运动医学领域应用范围的扩大。该地区强大的电子商务基础设施促进了产品的供应,而健康生活方式的兴起也推动了非药物疗法在传统退烧疗法之外的应用。不断上涨的医疗保健成本促使消费者寻求价格合理的自我护理替代方案,这将支撑全部区域市场的持续成长。
According to Stratistics MRC, the Global Cooling Gel Sheet Market is accounted for $1.15 billion in 2026 and is expected to reach $2.04 billion by 2034 growing at a CAGR of 7.4% during the forecast period. Cooling gel sheets are medical and personal care products designed to provide localized cooling therapy for fever management, headache relief, and minor injury treatment. These sheets adhere to the skin and offer sustained cooling without the mess of traditional ice packs. The market is expanding due to rising consumer awareness of non-pharmacological fever management, particularly in home healthcare settings.
Increasing prevalence of fever and heat-related illnesses
Rising cases of seasonal fevers, viral infections, and heat-related conditions are boosting demand for accessible cooling solutions. Consumers increasingly prefer convenient, drug-free alternatives to manage symptoms at home, especially for children and elderly family members. Cooling gel sheets offer immediate relief without oral medication side effects, making them a trusted first-line response. This trend is amplified by growing healthcare costs that encourage self-care practices.
Limited duration of cooling effect
The relatively short cooling duration of disposable sheets typically four to eight hours poses a constraint for users requiring extended symptom management. Frequent replacement increases overall cost and generates packaging waste, which may discourage regular use. Some consumers perceive disposable sheets as less economical compared to reusable ice packs. This limitation drives preference toward alternative cooling methods for prolonged fever episodes.
Expansion into sports medicine and post-surgical recovery
Untapped applications in sports injury management and post-operative care present significant growth avenues for cooling gel sheet manufacturers. Athletes increasingly adopt targeted cooling for inflammation reduction and recovery acceleration. Hospitals and clinics seek patient-friendly alternatives to bulky ice packs for post-surgical swelling management. These emerging use cases broaden the consumer base beyond traditional fever management.
Competition from alternative cooling therapies
The cooling gel sheet market faces intense competition from reusable gel packs, electronic cooling devices, and traditional cold compresses. These alternatives often offer longer cooling durations or lower lifetime costs. Consumers may choose multi-purpose products over specialized sheets. Additionally, the rise of wearable cooling technology presents a disruptive threat that could erode market share if innovation does not keep pace.
The pandemic drove heightened awareness of fever management as a key COVID-19 symptom, accelerating adoption of cooling gel sheets across households. Stockpiling behaviors led to temporary supply shortages. Home quarantine practices increased reliance on self-care products, while hospital settings prioritized non-pharmaceutical fever management to reduce staff exposure. This period permanently elevated baseline demand for cooling products.
The Disposable segment is expected to be the largest during the forecast period
Disposable cooling gel sheets dominate the market due to their convenience, hygiene, and ready-to-use format. Users appreciate the single-use application that eliminates cleaning or storage requirements, particularly for fever management in infants and children where contamination risks are a concern. These sheets are widely stocked in pharmacies and online retailers, ensuring broad accessibility. Their established consumer trust and affordability maintain market leadership.
The Adult segment is expected to have the highest CAGR during the forecast period
The adult target user segment is projected to witness the highest growth rate, driven by expanding applications beyond fever management into headache relief, post-exercise recovery, and menopausal hot flash mitigation. Working adults increasingly use cooling sheets for stress-induced tension headaches and heat stress during commutes. Marketing campaigns targeting active lifestyles and sports recovery are expanding adoption among younger adult demographics, creating sustained demand.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, supported by high population density, prevalent fever seasons, and strong cultural acceptance of cooling products for fever management. Countries including Japan, China, and India have well-established markets with widespread retail penetration and consumer familiarity. The region's aging population and growing middle class further fuel demand for convenient home healthcare solutions.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by increasing consumer awareness of non-pharmacological symptom management and expanding applications in sports medicine. The region's robust e-commerce infrastructure facilitates product accessibility, while wellness trends encourage adoption beyond traditional fever care. Rising healthcare costs push consumers toward affordable self-care alternatives, supporting sustained market growth across the region.
Key players in the market
Some of the key players in Cooling Gel Sheet Market include Kobayashi Pharmaceutical Co Ltd, Hisamitsu Pharmaceutical Co Inc, Lion Corporation, Beiersdorf AG, Johnson & Johnson, Reckitt Benckiser Group PLC, Taisho Pharmaceutical Holdings Co Ltd, Pigeon Corporation, Unicharm Corporation, Rohto Pharmaceutical Co Ltd, Amrutanjan Health Care Limited, Mentholatum Company Inc, Church & Dwight Co Inc, GlaxoSmithKline plc, and Prestige Consumer Healthcare Inc.
In February 2025, Unicharm Corporation completed a new manufacturing plant in Ahmedabad, India, to strengthen its local presence and distribution of hygiene and healthcare products, including cooling-related infant care items.
In February 2024, Rohto Pharmaceutical Co., Ltd. launched an AI-driven R&D project to optimize the chemical composition of its gel-based products, aiming for longer-lasting cooling effects and better skin compatibility.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.